Greg Mattingly
MD
Psychiatrist
Washington University

Dr. Mattingly is a physician and principal investigator in clinical trials for Midwest Research Group. He is also a founding partner of St. Charles Psychiatric Associates where he treats children, adolescents and adults. A St Louis native, he earned his medical degree and received a Fulbright scholarship while attending Washington University. Dr. Mattingly is board certified in adult and adolescent psychiatry and is a Diplomat of the National Board of Medical Examiners. He is an Associate Clinical Professor at Washington University where he teaches psychopharmacology courses for the 3rd year medical students. Dr. Mattingly has been a principal investigator in over 400 clinical trials focusing on ADHD, anxiety disorders, major depression, bipolar disorder and schizophrenia. Having served on numerous national and international advisory panels, Dr. Mattingly has received awards and distinctions for clinical leadership and neuroscience research. Dr Mattingly is the President for APSARD-The American Professional Society of ADHD and Related Disorders and is on the Scientific Advisory Board for the Workd Federation of ADHD.. Having served on the board of Headway House, a community support program and as a certifed evaluator for both the NFL and MLB, Dr Mattingly is firm believer in holistic mental health, eductaion and advocacy.

Sessions

Register

Advanced Psychopharmacology Preconference: 2024 as a Watershed Moment in Advanced Psychopharmacology - Four Cutting Edge, Emerging Therapies

Tuesday, October 29, 2024
9:00 AM - 12:00 PM

Eric C. Arauz Memorial Keynote Address: Fireside Chat: The Walking Man – A Father and Son’s Journey to Confront the Suicide Crisis

Tuesday, October 29, 2024
6:30 PM - 7:30 PM

An Evidence-based Roadmap to the Initial Management of ADHD

Wednesday, October 30, 2024
9:00 AM - 10:15 AM

ADHD in Adult Women: Challenges and New Directions

Wednesday, October 30, 2024
10:30 AM - 11:45 AM

Emotional Spectrum: Differentiating Between Sadness, Depression, and Bipolar Disorder

Wednesday, October 30, 2024
3:00 PM - 4:15 PM

Pushing Progression Back: Using LAIs to Create Recovery-Focused Treatment Plans in Schizophrenia

Wednesday, October 30, 2024
4:30 PM - 5:45 PM

Developing an "Efficacy First" Mindset in the Treatment of MDD with Adjunctive Antipsychotics

Thursday, October 31, 2024
10:30 AM - 11:45 AM

Addressing the Stimulant Crisis in America

Friday, November 01, 2024
9:00 AM - 10:15 AM

Atypical Antipsychotics for Depressive Episodes: Clinical Considerations and Strategies in BD vs MDD

Friday, November 01, 2024
10:30 AM - 11:45 AM

Psych Congress 2024: Final Thoughts and Panel Discussion

Saturday, November 02, 2024
4:15 PM - 4:30 PM